Sonendo, Inc. (SONX) Stock Price & Analysis
Sonendo, Inc. (SONX) — price $1.28 (0.00%), as of the Nov 19, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
Sonendo, Inc. · SONX
Sonendo, Inc. is a commercial-stage medical technology firm specializing in devices for root canal treatment, notably the GentleWave System. The company also offers dental crown materials, proprietary liquid solutions, and practice management software for dental professionals in the US and Canada.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
Scored companies in the same industry:
Price & valuation
| Measure | Value |
|---|---|
| Latest provided price | $1.28 |
| Change on the day | 0.00% |
| Shares traded on the day | 50 |
Price & events
Other perspectives
Council score for Sonendo (SONX): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: May 26, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Apr 29, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Apr 29, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Sonendo (SONX), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Sonendo, Inc. (SONX) is the company analyzed here. It employs 129 people. In Q4 FY2024 it reported revenue of $8M and net income of -$6M.
What do the latest results show for Sonendo (SONX)?
Short answer · as of
The most recent reported quarter, Q4 FY2024, carried revenue of $8M. Against analyst estimates the company has EPS beat 3 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 FY2024 | $8M | -$6M | -$0.13 (diluted) |
| Q3 FY2024 | $8M | -$8M | -$0.08 (diluted) |
| Q2 FY2024 | $8M | -$7M | -$0.08 (diluted) |
| Q1 FY2024 | $7M | -$7M | -$0.07 (diluted) |
What are the financial strengths and risks for Sonendo (SONX)?
Short answer · as of
The distress and quality screens read Altman Z -22.22 · Piotroski F 5. Trailing ratios: ROA -76.5% · current ratio 0.84.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of -22.22 sits in the distress zone (elevated bankruptcy risk).
- Inconsistent delivery — missed Wall Street EPS estimates in 5 of the last 8 reported quarters.
What should you watch next at Sonendo (SONX)?
Short answer · as of
Analyst estimates on file carry FY2026 revenue $42.30M · EPS -46.56 · 1 analysts.
What the records here don't tell us
- The next earnings date is not yet scheduled in the calendar we read.
- No insider Form 4 transaction falls inside the window this page reads.
- The newest quarter held here (Q4 FY2024) was filed Mar 26, 2025 — 14 months ago.
- Fewer than two score snapshots exist, so no score trend is shown.
Checked against the records this page reads, on the dates shown above.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Revenue estimate
- $42.30M
- EPS estimate
- $-46.56
Measured against a quoted price of $1.28 (as of Nov 19, 2026).
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held SONX in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported SONX in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Common Questions About SONX
These answers are editorial: 1 of these 8 answers is drawn from the SONX research dossier (written Jun 15, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is SONX a good stock to buy?
Stock Expert AI does not rate SONX buy, sell or hold. Sonendo, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the SONX stock price today?
The last price recorded for Sonendo, Inc. (SONX), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
How does Sonendo, Inc. generate revenue from its product offerings?
Sonendo, Inc. generates revenue primarily through the sale of its advanced medical technology devices for root canal treatment, with the GentleWave System being a flagship product.
What are the key factors to evaluate for SONX?
Evaluate SONX on fundamentals, analyst consensus, and risk factors. The flagship GentleWave System offers an innovative, non-invasive approach to root canal cleaning. Not financial advice.
How frequently does SONX data refresh on this page?
SONX's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven SONX's recent stock price performance?
Sonendo, Inc. (SONX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative GentleWave System offers a differentiated, non-invasive approach to root canal treatment. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SONX overvalued or undervalued right now?
Sonendo, Inc. (SONX) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research SONX before investing?
Before investing in Sonendo, Inc. (SONX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 14 figures on this page — 8 from Financial Modeling Prep (FMP) and 6 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com